Publication | Closed Access
Inflammatory response and treatment tolerance of long‐term infusion of the anti‐GD<sub>2</sub> antibody ch14.18/CHO in combination with interleukin‐2 in patients with high‐risk neuroblastoma
16
Citations
15
References
2018
Year
LTI of ch14.18/CHO combined with s.c.IL-2 shows an improved tolerance in subsequent cycles allowing outpatient treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1